An interventional study of Standing + Tibial Nerve Stimulation in Spinal Cord Injury, sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-04-08.
Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 44 studies in Spinal Cord Injuries by University of British Columbia — 16 open to participants now, 18 under way, none of them phase 3. Spinal Cord Injuries · University of British Columbia.
Among the 44 studies in Spinal Cord Injuries by University of British Columbia, this one is the 24th largest by planned enrollment of the 38 interventional ones that give a count, is one of 5 that started in 2026, is one of 31 with no phase, reaches primary completion later than 8 of the 17 other live ones, and was the 41st registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →16 of the 44 studies in Spinal Cord Injuries by University of British Columbia are open now, in 2 countries. Recruiting first, the newest first:
University of British Columbia · Sites in Canada
Ages 19+
University of British Columbia · Sites in Canada
Ages 19+
University of British Columbia · Sites in Canada
Ages 19–65
University of British Columbia · Sites in Canada
Ages 19–60
University of British Columbia · Sites in Canada
Ages 19+
By country, each count listing its studies:
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 19 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
44 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 4 · Phase 3 1 · Phase 4 1
First in 2004; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 12 is below the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 22 across the 38 interventional studies, 47 across the 6 observational. Of the 21 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of British Columbia is the lead sponsor of 1,342 studies on the registry; 262 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
4 of the studies in Spinal Cord Injuries by University of British Columbia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07429305University of British ColumbiaCombined Tibial Nerve Stimulation and Standing for People With SCI | 2026-12-31 |
| NCT05638191University of British ColumbiaNerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury | 2027-04 |
| NCT07519928University of British ColumbiaExploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for People With Spinal Cord Injury | 2027-09-30 |
| NCT06587841University of British ColumbiaNoninvasive Spinal Cord Stimulation for Early SCI | 2027-10-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 44 studies in Spinal Cord Injuries by University of British Columbia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to understand how sensory inputs from the lower leg can influence pelvic floor muscle function and urogential function in adults with chronic spinal cord injury (SCI). The main questions it aims to answer are:
Participants will be asked complete a series of assessments (questionnaires, electrophysiological testing) before and after a 12-week intervention of combined standing and tibial nerve stimulation therapy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Standing + Tibial Nerve Stimulation
Standing (with the support of a standing frame) combined with transcutaneous tibial nerve stimulation 3x/week for 12 weeks.
Pelvic Floor Muscle Reflex Excitability
We will electrically stimulate the tibial nerve and record reflexes responses from the pelvic floor muscles using perianal surface electromyography. We will examine the amplitude of the reflex response.
Time frame: At baseline to within 2 weeks of completing the study intervention
Feasibility - Recruitment Rate
Recruitment rate will be evaluated by number of participants approached, screened for eligibility, as well as reasons for exclusions.
Time frame: Through study completion, an average of 8 months
Feasibility - Adherence
Adherence will be tracked by the compliance of participants to the intervention, with reasons for missed sessions or drop-outs noted.
Time frame: Through study completion, an average of 8 months
Feasibility - Adverse Events
Any adverse events to study protocols will be recorded.
Time frame: Through study completion, an average of 8 months
Acceptability
The acceptability of the intervention will be evaluated using a 7-point Likert scale to rate participants' opinions about the intervention (enjoyment and perceived benefits) and the outcome measures (tolerability and appropriateness of the measurement procedures). A higher score indicates a more acceptable intervention.
Time frame: Through study completion, an average of 3 months
Neurogenic Bladder Symptoms Score (NBSS)
Participants will be asked to respond to 24 questions regarding the severity of their bladder symptoms secondary to neurological injury. Questions cover three subdomains: incontinence, storage and voiding, and consequences. The total score on this questionnaire ranges from 0-74, where a lower score represents less severe symptoms.
Time frame: Through study completion, an average of 8 months
Incontinence Quality of Life Questionnaire (I-QoL)
Participants will be asked to respond to 22 questions about how urinary incontinence impacts their quality of life using a 5-point scale with values ranging from 1 (extremely) to 5 (not at all). The questionnaire probes three subdomains of how incontinence may affect quality of life: avoidance and limiting behavior, psychosocial impact, and social embarrassment. Total score on this questionnaire ranges from 0-100, where a higher score represents higher quality of life.
Time frame: Through study completion, an average of 8 months
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Apr 2026; primary completion for Dec 2026, 8 months later.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 8 months is below that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of British Columbia →